Aclaris Therapeutics, Inc.
ACRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15 | -$15 | -$15 | -$97 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $4 | $3 |
| Change in WC | $1 | $1 | -$2 | -$1 |
| Other Non-Cash | $3 | $2 | $0 | $86 |
| Operating Cash Flow | -$11 | -$10 | -$13 | -$9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$36 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$5 | -$20 | -$10 | -$70 |
| Inv. Sales/Matur. | $19 | $25 | $30 | $18 |
| Other Inv. Act. | $0 | $0 | -$1 | $0 |
| Investing Cash Flow | $14 | $5 | $19 | -$89 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $75 |
| Stock Repurch. | $0 | -$0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | $0 | $0 | -$0 |
| Financing Cash Flow | -$3 | -$0 | -$0 | $75 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$0 | -$5 | $6 | -$23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25 | $30 | $25 | $48 |
| End Cash | $25 | $25 | $30 | $25 |
| Free Cash Flow | -$11 | -$10 | -$13 | -$45 |